- Home
- TLSA vs SNCR Comparison
TLSA vs SNCR Comparison
Compare TLSA & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- SNCR
- Stock Information
- Founded
- TLSA 2013
- SNCR 2000
- Country
- TLSA United Kingdom
- SNCR United States
- Employees
- TLSA N/A
- SNCR N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- SNCR EDP Services
- Sector
- TLSA Health Care
- SNCR Technology
- Exchange
- TLSA Nasdaq
- SNCR Nasdaq
- Market Cap
- TLSA 187.0M
- SNCR 70.9M
- IPO Year
- TLSA 2000
- SNCR 2006
- Fundamental
- Price
- TLSA $1.66
- SNCR $6.20
- Analyst Decision
- TLSA
- SNCR Strong Buy
- Analyst Count
- TLSA 0
- SNCR 1
- Target Price
- TLSA N/A
- SNCR $13.00
- AVG Volume (30 Days)
- TLSA 325.5K
- SNCR 62.9K
- Earning Date
- TLSA 05-06-2025
- SNCR 11-11-2025
- Dividend Yield
- TLSA N/A
- SNCR N/A
- EPS Growth
- TLSA N/A
- SNCR N/A
- EPS
- TLSA N/A
- SNCR N/A
- Revenue
- TLSA N/A
- SNCR $171,870,000.00
- Revenue This Year
- TLSA N/A
- SNCR $1.51
- Revenue Next Year
- TLSA N/A
- SNCR $5.43
- P/E Ratio
- TLSA N/A
- SNCR N/A
- Revenue Growth
- TLSA N/A
- SNCR 2.54
- 52 Week Low
- TLSA $0.63
- SNCR $5.25
- 52 Week High
- TLSA $2.60
- SNCR $15.46
- Technical
- Relative Strength Index (RSI)
- TLSA 43.10
- SNCR 50.58
- Support Level
- TLSA $1.63
- SNCR $5.41
- Resistance Level
- TLSA $1.88
- SNCR $6.27
- Average True Range (ATR)
- TLSA 0.15
- SNCR 0.30
- MACD
- TLSA -0.01
- SNCR 0.10
- Stochastic Oscillator
- TLSA 38.46
- SNCR 84.07
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.